ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMFlussi di cassa derivanti dalle attività di investimento-7.96 M-375.82 M-9.51 M-2.31 M-10.72 M-398.36 MLiquidità derivante dalle attività di finanziamento-179 K293.04 M0594.69 M-3.61 M884.12 MLiquidità libera-47.21 M-109 M34.65 M-127.89 M-43.12 M-245.35 M
Tempus AI, Inc. Class A
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."